AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Early and Objective Assessment of Neurological Prognosis in Cardiac Arrest Patients

Recruitingn/aAges 18 Years - anyAllNantes University Hospital
💬

In plain words

What the trial is, and whether it could suit you

Cerebral lesions are responsible for two thirds of deaths in patients admitted to intensive care following cardiac arrest. Patients with neurological lesions should be the priority target for neuroprotective interventions, which are the cornerstone of post-cardiac arrest care (allowing a reduction in the burden of care for patients without this type of lesion). Furthermore, these interventions must be based on a precise assessment of the severity of these brain lesions: carrying out neuro-protective interventions in patients without brain lesions exposes these patients to unnecessary treatment potentially associated with adverse effects without any possible benefit. However, the early assessment of neurological prognosis, particularly on admission to intensive care, is an area where there is little research and where it is not possible to obtain a precise and reproducible assessment. Sev

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years * Admitted to intensive care with out-of-hospital cardiac arrest * Comatose on admission (defined by a Glasgow score ≤ 8) * Informed relative who has consented to the patient's participation in the study or inclusion under emergency procedure if the relative is absent at the time of inclusion Exclusion Criteria: * In-hospital cardiac arrest * Age \< 18 years * Person under guardianship or legal protection * Prior inclusion in the study
💊

What it tests

  • Not listed
📍

Where

4 sites
CHD Vendée
La Roche-sur-Yon, France
CHU Nantes
Nantes, France
APHP - Hôpital Cochin
Paris, France
CH Saint-Nazaire
Saint-Nazaire, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy